JOHN BELMONT, PHD
Medical Practice at Fannin St, Houston, TX
License number
Texas F9186
Category
Medical Practice
Type
Pediatrics
License number
Texas F9186
Category
Medical Practice
Type
Clinical Genetics (M.D.)
Address
Address
6701 Fannin St, Houston, TX 77030
Phone
(832) 822-4280
(832) 825-4294 (Fax)
(832) 825-4294 (Fax)
Personal information
See more information about JOHN BELMONT at radaris.comName
Address
Phone
2725 Harvard Ave, San Angelo, TX 76904
4431 Lymbar Dr, Houston, TX 77096
2725 Harvard Ave, San Angelo, TX 76904
3425 Ymca Dr, San Angelo, TX 76904
2555 Braeswood Sq, Houston, TX 77025
Organization information
See more information about JOHN BELMONT at bizstanding.comJohn Belmont MD,PHD
6701 Fannin St, Houston, TX 77030
Industry:
Genetic Medicine, Pediatrician
Phone:
(832) 822-4280 (Phone)
Description:
There are 19 doctors at this site. Surgery is not performed at this site.
John William Belmont
Professional information
John W Belmont, Houston TX
Specialties:
Pediatrician
Address:
6701 Fannin St, Houston, TX 77030
1100 Bates Ave, Houston, TX 77030
1100 Bates Ave, Houston, TX 77030
Education:
Baylor University, College of Medicine - Doctor of Medicine
Baylor Clinic & Hospital - Fellowship - Medical Genetics
Baylor Clinic & Hospital - Residency - Pediatrics
Children's National Medical Center - Residency - Pediatrics
Children's National Medical Center - Internship - Pediatrics
Baylor Clinic & Hospital - Fellowship - Medical Genetics
Baylor Clinic & Hospital - Residency - Pediatrics
Children's National Medical Center - Residency - Pediatrics
Children's National Medical Center - Internship - Pediatrics
Board certifications:
American Board of Medical Genetics Certification in Clinical Biochemical Genetics (Medical Genetics), American Board of Medical Genetics Certification in Clinical Genetics (MD) (Medical Genetics), American Board of Pediatrics Certification in Pediatrics
Dr. John Belmont - PHD
Specialties:
Pediatrics, Clinical Biochemical Genetics, Clinical Genetics
Certifications:
Clinical Biochemical Genetics, 2004, Clinical Genetics, 1987, Pediatrics, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Texas Childrens Hospital General
6701 Fannin St SUITE 1560, Houston 77030
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
The Methodist Hospital
6565 Fannin St, Houston 77030
Texas Childrens Hospital General
6701 Fannin St SUITE 1560, Houston 77030
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
The Methodist Hospital
6565 Fannin St, Houston 77030
6701 Fannin St SUITE 1560, Houston 77030
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
The Methodist Hospital
6565 Fannin St, Houston 77030
Texas Childrens Hospital General
6701 Fannin St SUITE 1560, Houston 77030
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
The Methodist Hospital
6565 Fannin St, Houston 77030
Education:
Medical School
Baylor College Of Medicine
Graduated: 1981
Chldns Hospital
Graduated: 1982
Baylor Affil Hosps
Graduated: 1984
Graduated: 1983
Baylor
Graduated: 1985
Baylor College Of Medicine
Graduated: 1981
Chldns Hospital
Graduated: 1982
Baylor Affil Hosps
Graduated: 1984
Graduated: 1983
Baylor
Graduated: 1985
John William Belmont, Houston TX
Specialties:
Pediatrics, Medical Genetics, Clinical Biochemical Genetics, Clinical Genetics, M.D., Cardiovascular Disease
Work:
Texas Childrens Physician Group
6701 Fannin St, Houston, TX 77030 Baylor College of Medicine
1 Baylor Plz, Houston, TX 77030 Texas Childrens Physician Group
6620 Main St, Houston, TX 77030
6701 Fannin St, Houston, TX 77030 Baylor College of Medicine
1 Baylor Plz, Houston, TX 77030 Texas Childrens Physician Group
6620 Main St, Houston, TX 77030
Education:
Baylor College of Medicine (1981)
John Belmont
Location:
Houston, Texas Area
Industry:
Biotechnology
Phosphatases Which Activate Map Kinase Pathways
US Patent:
7195902, Mar 27, 2007
Filed:
Mar 18, 2004
Appl. No.:
10/803738
Inventors:
John W. Belmont - Houston TX, US
Frederick A. Fletcher - Ventura CA, US
Alice J. Chen - Houston TX, US
Roland Jurecic - Key Biscayne FL, US
Tse-Hua Tan - Houston TX, US
Guisheng Zhou - Houston TX, US
Frederick A. Fletcher - Ventura CA, US
Alice J. Chen - Houston TX, US
Roland Jurecic - Key Biscayne FL, US
Tse-Hua Tan - Houston TX, US
Guisheng Zhou - Houston TX, US
Assignee:
Amgen Corporation - Seattle WA
Baylor College of Medicine - Houston TX
Baylor College of Medicine - Houston TX
International Classification:
C12N 9/14
US Classification:
435195, 435196, 536 232
Abstract:
The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.
Double Transdominant Fusion Gene And Protein
US Patent:
2005026, Nov 24, 2005
Filed:
Aug 27, 2003
Appl. No.:
10/648954
Inventors:
John Belmont - Houston TX, US
J. Harper - Sugar Land TX, US
Andrew Rice - Houston TX, US
Janet Butel - Houston TX, US
Javier Chinen - Houston TX, US
J. Harper - Sugar Land TX, US
Andrew Rice - Houston TX, US
Janet Butel - Houston TX, US
Javier Chinen - Houston TX, US
International Classification:
C12Q001/68, C12P021/06, C12P019/34, C12N005/00, C12N005/02
US Classification:
435091330, 435006000, 435069100, 435325000
Abstract:
A double transdominant fusion gene (trev) to simultaneously inhibit two functions essential for HIV expression was constructed by linking tat and rev transdominant mutants. Trev was shown to independently inhibit both Tat and Rev functions in a human T cell line. Stably expressed Trev localized within the nucleus and exhibited a greater combinatorial effect than either single transdominant gene alone. Cells transfected with Trev showed a stable 20 to 30 fold inhibition of HIV propagation and were protected against viral cytopathic effects. Simultaneous inhibition of two essential viral genes present significant advantages for potential gene therapy treatment of HIV infection.
Phosphatases Which Activate Map Kinase Pathways
US Patent:
2010027, Oct 28, 2010
Filed:
Jan 22, 2007
Appl. No.:
11/656334
Inventors:
John W. Belmont - Houston TX, US
Frederick A. Fletcher - Ventura CA, US
Alice J. Chen - Houston TX, US
Roland Jurecic - Key Biscayne FL, US
Tse-Hua Tan - Houston TX, US
Guisheng Zhou - Houston TX, US
Frederick A. Fletcher - Ventura CA, US
Alice J. Chen - Houston TX, US
Roland Jurecic - Key Biscayne FL, US
Tse-Hua Tan - Houston TX, US
Guisheng Zhou - Houston TX, US
Assignee:
Amgen Inc. - Thousand Oaks CA
Baylor College of Medicine - Houston TX
Baylor College of Medicine - Houston TX
International Classification:
A61K 31/7052, C07H 21/00, C12N 15/55, C12N 15/63, C12N 5/07, C12N 1/00, C12N 9/16, C07K 16/00, C12Q 1/42, G01N 33/53, A61P 9/10, A61P 13/12, A61P 1/16, A61P 11/00, A61P 19/02, A61P 29/00, A61P 37/06
US Classification:
514 44 R, 536 221, 536 232, 4353201, 435325, 435243, 435196, 5303879, 5303873, 435 21, 435 78
Abstract:
The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.
Phosphatases Which Activate Map Kinase Pathways
US Patent:
6900043, May 31, 2005
Filed:
Sep 20, 2000
Appl. No.:
09/665819
Inventors:
John W. Belmont - Houston TX, US
Frederick A. Fletcher - Ventura CA, US
Alice J. Chen - Houston TX, US
Roland Jurecic - Key Biscayne FL, US
Tse-Hua Tan - Houston TX, US
Guisheng Zhou - Houston TX, US
Frederick A. Fletcher - Ventura CA, US
Alice J. Chen - Houston TX, US
Roland Jurecic - Key Biscayne FL, US
Tse-Hua Tan - Houston TX, US
Guisheng Zhou - Houston TX, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C12N009/16
US Classification:
435196, 435195, 43525233, 43525411, 435325, 4353201, 435536, 435 232, 435 235
Abstract:
The present invention provides novel JNK activating phosphatase polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing JNK activating phosphatase polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with JNK activating phosphatase polypeptides.